10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 364 filers reported holding 10X GENOMICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,601,832 | -26.1% | 38,823 | +0.0% | 0.00% | 0.0% |
| Q2 2023 | $2,167,014 | -0.1% | 38,811 | -0.1% | 0.00% | 0.0% |
| Q1 2023 | $2,168,191 | +297.1% | 38,860 | +159.4% | 0.00% | – |
| Q4 2022 | $546,051 | +27.8% | 14,979 | -50.0% | 0.00% | – |
| Q3 2022 | $427,427 | -44.1% | 29,958 | +77.5% | 0.00% | -100.0% |
| Q2 2022 | $764,000 | -82.1% | 16,879 | -69.9% | 0.00% | -50.0% |
| Q1 2022 | $4,269,000 | -88.9% | 56,111 | -78.2% | 0.00% | -87.5% |
| Q4 2021 | $38,373,000 | +644.0% | 257,610 | +627.2% | 0.02% | +700.0% |
| Q3 2021 | $5,158,000 | +575.1% | 35,427 | +808.9% | 0.00% | – |
| Q2 2021 | $764,000 | -85.1% | 3,898 | -89.2% | 0.00% | -100.0% |
| Q4 2020 | $5,125,000 | +256.9% | 36,192 | +27.1% | 0.00% | +100.0% |
| Q3 2019 | $1,436,000 | – | 28,481 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |